• Explore /
  • Poster
  • / Multi-institutional european single-arm phase II trial of pazopanib in advanced typical solitary fibrous tumors (SFT): A collaborative Spanish (GEIS), Italian (ISG), and French (FSG) sarcoma groups study.

Multi-institutional european single-arm phase II trial of pazopanib in advanced typical solitary fibrous tumors (SFT): A collaborative Spanish (GEIS), Italian (ISG), and French (FSG) sarcoma groups study.

Abstract Poster

Authors

null

Josefina Cruz Jurado

Hospital Universitario de Canarias, GEICAM Spanish Breast Cancer Group, Santa Cruz de Tenerife, Spain

Josefina Cruz Jurado , Sarah Naomie Dumont , Nicolas Penel , Pablo Luna Fra , Enrique Alava , Nadia Hindi , Jean-Yves Blay , Silvia Stacchiotti , Paola Collini , Andres Redondo , Daniel Bernabeu , Antonio Lopez-Pousa , Giovanni Grignani , David Silva Moura , Javier Martinez-Trufero , Philippe Terrier , Marie Karanian , Axel Le Cesne , Paolo Giovanni Casali , Javier Martin Broto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT02066285

Citation

J Clin Oncol 37, 2019 (suppl; abstr 11038)

DOI

10.1200/JCO.2019.37.15_suppl.11038

Abstract #

11038

Poster Bd #

361

Abstract Disclosures

Similar Posters

First Author: Silvia Stacchiotti

Poster

2022 ASCO Annual Meeting

A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma.

A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma.

First Author: Sujana Movva

First Author: Keun-Wook Lee

First Author: Chetan Vakkalagadda